Jonathan Kropski
Pulmonary Disease · Nashville, TNNPI 1598939985
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,973 of the $40,874 with a category attached, or 83.1%. Boehringer Ingelheim accounts for 80.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $21,065 and has fallen 61.9% since, to $8,033 in 2025. Among pulmonary disease clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $717.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$33K
- Janssen Research & Development, LLC$5K
- Boehringer Ingelheim Pharma GmbH & Co.kg$2K
- Vertex$333
- Genentech USA, Inc.$240
- Genentech, Inc.$23
Across 3 payments — averaging $126,083 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$378K
What the payments were for
- Consulting fees$33,97383%
- Speaking & faculty fees$9452%
- Travel & lodging$3,6879%
- Food & beverage$2,2696%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 50 | $32,688 |
| Janssen Research & Development, LLC | 2 | $5,250 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $2,340 |
| Vertex | 1 | $333 |
| Genentech USA, Inc. | 2 | $240 |
| Genentech, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,874 in reported general payments places this provider in the 90th percentile of 339 pulmonary disease providers in Tennessee.
Other pulmonary disease in Nashville
- Lisa LancasterNashville$519K
- Otis RickmanNashville$392K
- Susan GarwoodNashville$343K
- Joao DeandradeNashville$245K
- Anna HemnesNashville$183K
- Bryan HayNashville$126K
- Karl KuhnNashville$106K
- Fabien MaldonadoNashville$83K
- Margaret SalisburyNashville$53K
- Victor KhaNashville$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.